← Leaderboards
William W Eaton
Johns Hopkins University
$22,660,492
Attributed
$28,029,657
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$28,029,657 · 11
By mechanism
R01$17,189,117 · 5
U01$5,720,686 · 1
T32$4,239,937 · 1
R34$712,305 · 1
R03$163,500 · 1
M01$4,112 · 2
Top collaborators
- Deanna L Kelly9 shared
- Adam Peter Spira9 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Mollie K Meffert$8,768,463
- Eric L Nuermberger$20,859,483
- Paula W Fomby$5,477,298
- Aisha S. Dickerson$485,865
- Daniel J McBride$591,793
Others in their field
Top investigators on “Link”
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- David R. Weir · University Of Michigan At Ann Arbor$206,261,870
- Clare E Reimers · Gordon Research Conferences$205,233,456
- Demian A Bailey · Oregon State University$205,233,456
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
Research focus
LinkParticipantMental DisordersCohortDiagnosisInterviewSamplingBaseSchizophreniaRecording Of Previous EventsBaltimorePharmaceutical PreparationsBloodPopulation BasedEpidemiologyPhenotypePersonsAlzheimer&AposMood DisordersImpaired CognitionDisabilityAreaFollow-UpLiterature
Grant awards (59)
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study - Covid Supplement$818,747
U01 · FY2021 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$773,272
R01 · FY2021 · MH
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$1,100,817
U01 · FY2020 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$955,279
R01 · FY2020 · MH
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$374,398
U01 · FY2020 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$211,977
R01 · FY2020 · MH
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$780,579
R01 · FY2019 · MH
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$769,590
U01 · FY2019 · AG
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$347,938
U01 · FY2019 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$783,201
R01 · FY2018 · MH
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$552,460
U01 · FY2018 · AG
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$807,391
U01 · FY2017 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies$801,031
R01 · FY2017 · MH
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$161,988
U01 · FY2017 · AG
Stress Mental Disorders Accelerated Aging and Dementia a 35 year Cohort Study$787,357
U01 · FY2016 · AG
Development for RCT of Gluten Free Diet in Gliadin-Positive Schizophrenia$193,532
R34 · FY2015 · MH · contact PI
Development for RCT of Gluten Free Diet in Gliadin-Positive Schizophrenia$235,886
R34 · FY2014 · MH · contact PI
Development for RCT of Gluten Free Diet in Gliadin-Positive Schizophrenia$282,887
R34 · FY2013 · MH · contact PI
Evolution of Psychopathology in the Population$133,244
R01 · FY2013 · DA · contact PI
Evolution of Psychopathology in the Population$471,806
R01 · FY2012 · DA · contact PI
Risks for Transitions in Drug use Among Urban Adults$757,492
R01 · FY2011 · DA · contact PI
Evolution of Psychopathology in the Population$552,662
R01 · FY2011 · DA · contact PI
Risks for Transitions in Drug use Among Urban Adults$733,379
R01 · FY2010 · DA · contact PI
Evolution of Psychopathology in the Population$542,744
R01 · FY2010 · DA · contact PI
Psychiatric Epidemiology Training Program$323,650
T32 · FY2010 · MH · contact PI
Psychosis and Autoimmune Diseases in Denmark$148,389
R01 · FY2010 · MH · contact PI
Risks for Transitions in Drug use Among Urban Adults$737,983
R01 · FY2009 · DA · contact PI
Evolution of Psychopathology in the Population$619,555
R01 · FY2009 · DA · contact PI
Psychiatric Epidemiology Training Program$297,578
T32 · FY2009 · MH · contact PI
Psychosis and Autoimmune Diseases in Denmark$148,389
R01 · FY2009 · MH · contact PI
Evolution of Psychopathology in the Population$57,970
R01 · FY2009 · DA · contact PI
Risks for Transitions in Drug use Among Urban Adults$724,316
R01 · FY2008 · DA · contact PI
Psychiatric Epidemiology Training Program$352,892
T32 · FY2008 · MH · contact PI
Psychosis and Autoimmune Diseases in Denmark$184,218
R01 · FY2008 · MH · contact PI
Risks for Transitions in Drug use Among Urban Adults$713,244
R01 · FY2007 · DA · contact PI
Psychiatric Epidemiology Training Program$363,806
T32 · FY2007 · MH · contact PI
Psychosis and Autoimmune Diseases in Denmark$184,115
R01 · FY2007 · MH · contact PI
BALTIMORE HEALTH AND MENTAL HEALTH STUDY$3,564
M01 · FY2007 · RR · contact PI
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$723,682
R01 · FY2006 · MH · contact PI
Psychosis and Autoimmune Diseases in Denmark$225,900
R01 · FY2006 · MH · contact PI
BALTIMORE HEALTH AND MENTAL HEALTH STUDY$548
M01 · FY2006 · RR · contact PI
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$743,408
R01 · FY2005 · MH
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAM$434,669
T32 · FY2005 · MH
Pilot Studies for Baltimore CPP/Pathways Followup$81,750
R03 · FY2005 · MH
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$1,211,979
R01 · FY2004 · MH
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAM$543,161
T32 · FY2004 · MH
BIRTH RISK AND SEVERE MENTAL DISORDERS IN DENMARK$131,750
R01 · FY2004 · MH
Pilot Studies for Baltimore CPP/Pathways Followup$81,750
R03 · FY2004 · MH
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$1,192,604
R01 · FY2003 · MH
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAM$580,011
T32 · FY2003 · MH
BIRTH RISK AND SEVERE MENTAL DISORDERS IN DENMARK$173,895
R01 · FY2003 · MH
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$1,005,023
R01 · FY2002 · MH
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAM$549,441
T32 · FY2002 · MH
BIRTH RISK AND SEVERE MENTAL DISORDERS IN DENMARK$172,625
R01 · FY2002 · MH
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAM$516,821
T32 · FY2001 · MH
BIRTH RISK AND SEVERE MENTAL DISORDERS IN DENMARK$207,975
R01 · FY2001 · MH
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$119,163
R01 · FY2001 · MH
PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAM$277,908
T32 · FY2000 · MH
EVOLUTION OF PSYCHOPATHOLOGY IN THE POPULATION$266,268
R01 · FY2000 · MH